83 results
DEFA14A
STRO
Sutro Biopharma Inc
26 Apr 24
Additional proxy soliciting materials
4:30pm
Statement
☒ Definitive Additional Materials
☐ Soliciting Material Pursuant to §240.14a-12
SUTRO BIOPHARMA, INC.
(Name of Registrant as Specified … No fee required.
☐ Fee paid previously with preliminary materials.
☐ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a
8-K
EX-1.1
STRO
Sutro Biopharma Inc
2 Apr 24
Entry into a Material Definitive Agreement
5:10pm
the statements therein, in the light of the circumstances under which they were made, not misleading.
(g)Distribution of Offering Materials. The Company … than the Prospectus and other materials, if any, permitted under the Securities Act and consistent with Section 4(b) below. The Company will file
424B5
STRO
Sutro Biopharma Inc
2 Apr 24
Prospectus supplement for primary offering
4:58pm
“Where You Can Find More Information” for information concerning how to read and obtain copies of materials that we file with the SEC.
Any statement … of this prospectus entitled “Where You Can Find More Information” for information concerning how to obtain copies of materials that we file with the SEC.
Any
8-K
EX-1.1
vdrk40
9 Feb 24
Other Events
4:27pm
424B5
g9pec393
9 Feb 24
Prospectus supplement for primary offering
4:25pm
8-K
EX-99.1
9kl0gpv0i1mlj1d
8 Jan 24
Results of Operations and Financial Condition
7:31am
8-K
3gjwpa7gidv
27 Nov 23
Entry into a Material Definitive Agreement
4:05pm
8-K
EX-99.1
ex6d6qxo
15 May 23
Sutro Biopharma Reports First Quarter 2023 Financial Results, Business Highlights and Select Anticipated Milestones
8:01am
DEFA14A
yxmglut694btbchg 7q
28 Apr 23
Additional proxy soliciting materials
4:06pm